Stay updated on Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.

Latest updates to the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page
- Check6 days agoChange DetectedThe page footer revision label was updated from v3.6.2 to v3.6.3, indicating a minor release update to the study page rendering.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page revision updated from v3.6.0 to v3.6.2. This indicates a minor internal update to the page metadata.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not enrolling. New navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and a UI revision note (Revision: v3.6.0) were added, and the Intervention header formatting was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.5%

- Check34 days agoChange DetectedThe footer now shows a new revision label: v3.5.5, replacing the previous v3.5.4. This represents a minor update to the page version.SummaryDifference0.1%

- Check55 days agoChange DetectedThe site revision tag was updated from v3.5.3 to v3.5.4. This appears to be a behind-the-scenes update with no visible changes to the study details or user-facing content.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page header/footer is updated to show a newer ClinicalTrials.gov site revision (v3.5.3 instead of v3.5.2), reflecting a platform release rather than a change to the underlying clinical trial information.SummaryDifference0.1%

Stay in the know with updates to Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.